InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
0
T+90 hit rate
36%
T+90 mean return
+14.0%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Vos Ellen O'Connor, Director. Insider active across 3 companies, notably OptimizeRx Corp. Aggregated, 16 filings have been recorded. Split: 3 buys · 0 sell. Total volume traded: €150k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 4 June 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations16 total
5,312 shares0Common StockSEC:0001641172-25-014017:0
5,313 shares0Common StockSEC:0001641172-25-002278:0
5,312 shares0Common StockSEC:0001562180-25-000277:0
5,313 shares0Common StockSEC:0001562180-24-007233:0
16,593 shares0Common StockSEC:0000950170-24-096244:0
3,268 sharesCommon StockSEC:0000950170-24-082709:0
10,061 shares0Common StockSEC:0001628280-24-027715:0
4,637 shares0Common StockSEC:0001628280-23-029926:0
3,769 shares@ US$3.98100.0% of flowCommon StockSEC:0000926617-23-000061:0
Ideal exit: 19 Apr 2024 (T+270)
29,109 shares0Common StockSEC:0001562180-23-004817:0
657 shares0Common StockSEC:0001628280-23-010319:0
409 shares0Common StockSEC:0001628280-23-000213:0
334 shares0Common StockSEC:0001628280-22-025807:0
500 shares@ US$15.91100.0% of flowCommon StockSEC:0001213900-22-049031:0
Ideal exit: 13 May 2023 (T+270)
55,555 shares@ US$2.700.70% mcap50.0% of flowCommon StockSEC:0001019056-21-000555:0
Ideal exit: 25 Jul 2022 (T+270)
407 shares0Common StockSEC:0001213900-21-035082:0
16 of 16 declarations
About Vos Ellen O'Connor
Vos Ellen O'Connor is the Chief Executive Officer and Board Member of OptimizeRx Corp and Modular Medical, Inc. She is responsible for the strategic direction of the companies and the management of their operations. Ellen plays a key role in developing policies and initiatives aimed at improving the performance of the companies. Her leadership is crucial for the growth and development of OptimizeRx and Modular Medical.
